Inter Pharma Public Company Limited
IP.BK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.98B
Close$
$14.71
200.2% upside
Current Fair Value
200.2% upsideUndervalued by 200.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.98 Billion |
|---|---|
| Enterprise Value | $3.11 Billion |
| Annual dividend | $0.07 |
| Dividend yield | 1.48% |
| Earnings per Share | $0.2 |
| Beta | 0.37 |
| Outstanding Shares | 605,344,000 |
Return
| Return on Equity | 6.62% |
|---|---|
| Return on Assets | 4.25% |
| Return on Invested Capital | 8.03% |
Valuation & Multiples
| P/E Ratio | 21.59 |
|---|---|
| PEG | 123.32 |
| Price to Sales | 1.63 |
| Price to Book Ratio | 1.63 |
| Enterprise Value to Revenue | 1.39 |
| Enterprise Value to EBIT | 14.79 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$177.00 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 17, 2026
EPS Estimate
$0.07
Consensus analyst estimateRevenue Estimate
$177.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Inter Pharma Public Company Limited
64 employees
CEO: Trinnawat Thanitnithiphan
Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in the manufacturing, importing, and distribution of a wide array of health and dietary supplements designed for both human and animal use. The company's operati...